Eva Biologics Profile
Key Indicators
- Authorised Capital ₹ 1.50 M
as on 02-12-2024
- Paid Up Capital ₹ 1.00 M
as on 02-12-2024
- Company Age 4 Year, 4 Months
- Last Filing with ROC 31 Mar 2023
- Revenue -51.88%
(FY 2022)
- Profit -73.11%
(FY 2022)
- Ebitda -68.20%
(FY 2022)
- Net Worth 407.47%
(FY 2022)
- Total Assets 111.23%
(FY 2022)
About Eva Biologics
The Company is engaged in the Life Sciences Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.50 M and a paid-up capital of Rs 1.00 M, as per Ministry of Corporate Affairs (MCA) records.
Ghanashyam Biswas, Birendra Banerjee, Paromita Chattoraj, and One other member serve as directors at the Company.
- CIN/LLPIN
U85300OR2020PTC034152
- Company No.
034152
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
15 Sep 2020
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Cuttack
Industry
Company Details
- Location
Khorda, Odisha, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Eva Biologics?
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Paromita Chattoraj  | Director | 15-Sep-2020 | Current |
| Birendra Banerjee | Director | 15-Sep-2020 | Current |
| Amit Chowdhury | Director | 15-Sep-2020 | Current |
| Ghanashyam Biswas | Additional Director | 02-Aug-2021 | Current |
Financial Performance of Eva Biologics.
Eva Biologics Private Limited, for the financial year ended 2022, experienced significant reduction in revenue, with a 51.88% decrease. The company also saw a substantial fall in profitability, with a 73.11% decrease in profit. The company's net worth Soared by an impressive increase of 407.47%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Eva Biologics?
Unlock access to Eva Biologics's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Sparsh Hospitals & Critical Care Private LimitedActive 17 years 8 monthsGhanashyam Biswas is a mutual person
Indna Lifesciences Private LimitedActive 12 years 8 monthsBirendra Banerjee and Paromita Chattoraj are mutual person
- Sparsh Optimum Healthcare Private LimitedActive 42 years 1 month
Ghanashyam Biswas is a mutual person
- Pranvayu Seva Private LimitedActive 4 years 4 months
Birendra Banerjee and Paromita Chattoraj are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Eva Biologics?
Eva Biologics has a workforce of 0 employees as of Apr 08, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Eva Biologics, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Eva Biologics's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
